US · Real Estate

HH Biotechnology Holdings Company (HHBT)

Real Estate Services

HH Biotechnology Holdings Company (HHBT) is listed on US in the Real Estate sector. Industry: Real Estate Services. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for HHBT

P/E ratio

18.00

HH Biotechnology Holdings Company (HHBT) — FAQ

What is HHBT's P/E ratio?

The price-to-earnings (P/E) ratio for HH Biotechnology Holdings Company (HHBT) is 18.00 (data as of 2026-03-24).

Does HH Biotechnology Holdings Company pay a dividend?

Dividend yield is not available in the current snapshot for HH Biotechnology Holdings Company (HHBT). Check the MyAverix Finance app for the latest dividend data.

What sector is HH Biotechnology Holdings Company in?

HH Biotechnology Holdings Company (HHBT) is classified in the Real Estate sector (Real Estate Services industry).

What exchange is HHBT listed on?

HHBT is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Real Estate companies

AvalonBay Communities Inc. (A1VB34) CBRE Group Inc. (C1BR34) Central Pattana Public Company Limited (CPN-R) China Overseas (0688) CK Asset Holdings Ltd (1113) Digital Realty Trust, Inc. (D1LR34) Equity Residential (E1QR34) Gould Investors L.P (GDVTZ)